5.74

0.00% 0.00

Protara Therapeutics Inc (TARA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$5.74

Offen:

$5.8

24-Stunden-Volumen:

1.34M

Relative Volume:

1.81

Marktkapitalisierung:

$296.36M

Einnahmen:

Nettoeinkommen (Verlust:

$-42.05M

KGV:

-2.0355

EPS:

-2.82

Netto-Cashflow:

$-35.26M

1W Leistung:

-15.59%

1M Leistung:

+26.71%

6M Leistung:

+70.33%

1J Leistung:

-8.16%

1-Tages-Spanne:

$5.55

$5.80

1-Wochen-Bereich:

$5.07

$7.05

52-Wochen-Spanne:

$2.77

$7.82

Protara Therapeutics Inc Stock (TARA) Company Profile

Firmenname

Protara Therapeutics Inc

Sektor

Healthcare (1124)

Branche

Biotechnology (627)

Telefon

646-844-0337

Adresse

345 PARK AVENUE SOUTH, NEW YORK, NY

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-05

Neueste SEC-Einreichungen

TARA's Discussions on Twitter

Vergleichen Sie TARA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TARA Protara Therapeutics Inc	5.74	296.36M	0	-42.05M	-35.26M	-2.82
VRTX Vertex Pharmaceuticals Inc	444.64	110.88B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	726.21	72.79B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	890.11	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	404.46	54.85B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	189.85	41.41B	447.02M	-1.18B	-906.14M	-6.1812

Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-16	Eingeleitet	Scotiabank	Sector Outperform
2025-03-14	Eingeleitet	Cantor Fitzgerald	Overweight
2023-07-10	Fortgesetzt	Guggenheim	Buy
2021-06-04	Eingeleitet	H.C. Wainwright	Buy
2021-02-17	Eingeleitet	Oppenheimer	Outperform
2020-10-19	Eingeleitet	Cowen	Outperform
2020-07-29	Eingeleitet	Guggenheim	Buy

Alle ansehen

Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten

Dec 09, 2025

Protara therapeutics raises $75 million in public offering By Investing.com - Investing.com India

Dec 08, 2025

Protara Announces Closing of $75 Million Public Offering - The Manila Times

Dec 08, 2025

Dec 07, 2025

Protara Therapeutics slumps 12%, raises $75M equity at $5.75 per share - MSN

Dec 07, 2025

Protara announces proposed public offering - MSN

Dec 07, 2025

Is Protara Therapeutics Inc a good long term investmentOptions Trading Strategies & High Return Trading Strategies - earlytimes.in

Dec 07, 2025

Dec 05, 2025

Protara Therapeutics: Stock Offer Takes the Spotlight - StocksToTrade

Dec 05, 2025

Protara Prices $75 Mln Offering To Advance TARA-002 And Broader Pipeline - Nasdaq

Dec 05, 2025

Biotech co Protara slides on $75 mln share sale - TradingView

Dec 05, 2025

Protara Therapeutics Shares Sink 16% After $75 Mln Public Offering - Nasdaq

Dec 05, 2025

Protara Therapeutics (Nasdaq: TARA) prices 13,043,479-share, $75M public deal - Stock Titan

Dec 05, 2025

Protara Therapeutics (TARA) Launches $75M Public Offering - GuruFocus

Dec 05, 2025

Protara Therapeutics Prices $75 Million Share Offering - marketscreener.com

Dec 05, 2025

Will Protara Therapeutics Inc. (1KPA) stock benefit from sector leadershipJuly 2025 Price Swings & Accurate Trade Setup Notifications - Newser

Dec 05, 2025

Protara Therapeutics prices $75 million public offering By Investing.com - Investing.com Nigeria

Dec 05, 2025

TARA Stock Offering Priced at Lower End of Target Range - GuruFocus

Dec 05, 2025

Dec 04, 2025

Protara Therapeutics prices $75 million public offering - Investing.com

Dec 04, 2025

Protara Announces Pricing of $75 Million Public Offering - The Manila Times

Dec 04, 2025

Protara prices public offering of 13.04 million shares at $5.75 each - marketscreener.com

Dec 04, 2025

Protara Announces Pricing of $75 Million Public Offering - GlobeNewswire Inc.

Dec 04, 2025

Key Managers Announced for TARA Offering - GuruFocus

Dec 04, 2025

Protara Therapeutics Launches Offering of Securities - marketscreener.com

Dec 04, 2025

Protara Therapeutics stock tumbles after $75M public offering By Investing.com - Investing.com Canada

Dec 04, 2025

Protara Therapeutics announces $75 million public offering - Investing.com

Dec 04, 2025

Protara Therapeutics stock tumbles after $75M public offering - Investing.com

Dec 04, 2025

Protara Therapeutics announces $75 million public offering By Investing.com - Investing.com South Africa

Dec 04, 2025

Protara Announces Proposed Public Offering - The Manila Times

Dec 04, 2025

Protara Therapeutics Announces $75 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative

Dec 04, 2025

Protara Therapeutics (Nasdaq: TARA) starts $75M stock and pre-funded warrant sale - Stock Titan

Dec 04, 2025

Protara Therapeutics (NASDAQ:TARA) Receives "Buy" Rating from HC Wainwright - MarketBeat

Dec 04, 2025

Protara’s cell therapy touts BCG-naïve treatment potential in Phase II - Yahoo Finance

Dec 04, 2025

Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naive NMIBC Patients - marketscreener.com

Dec 04, 2025

Protara Therapeutics: End Of 2025 Proving Eventful Indeed (NASDAQ:TARA) - Seeking Alpha

Dec 04, 2025

Why Protara Therapeutics Inc. (1KPA) stock is listed among top recommendationsEarnings Overview Report & Daily Stock Trend Reports - Newser

Dec 04, 2025

Protara Therapeutics (NASDAQ:TARA) Receives Buy Rating from HC Wainwright - Defense World

Dec 04, 2025

Dec 03, 2025

HC Wainwright & Co. Reiterates Protara Therapeutics (TARA) Buy Recommendation - Nasdaq

Dec 03, 2025

TARA: HC Wainwright & Co. Reiterates 'Buy' Rating with $23 Targe - GuruFocus

Dec 03, 2025

TARA: TARA-002 shows 69% six-month CR and strong safety in BCG naive NMIBC, advancing to registrational trial - TradingView

Dec 03, 2025

Protara Reports Updated Interim Phase 2 Data Of TARA-002 In Non-muscle Invasive Bladder Cancer - RTTNews

Dec 03, 2025

Protara Therapeutics reports positive results from bladder cancer study - Seeking Alpha

Dec 03, 2025